ALZN
Alzamend Neuro, Inc.
Company overview
- Market capitalization
- $8.35M
- Employees
- 4
- Latest publication
- 2026-09-29
About Alzamend Neuro, Inc.
Alzamend Neuro, Inc., a clinical-stage biopharmaceutical company, focuses on developing various products for the treatment of neurodegenerative and psychiatric disorders. Its pipeline includes AL001, which delivers a therapeutic combination of lithium, proline, and salicylate for the treatment of Alzheimer's, bi-polar disorder, post-traumatic stress disorder, major depressive disorder, other neurodegenerative diseases, and psychiatric disorders; and ALZN002, which uses a method using a mutant-peptide sensitized cell as a cell-based therapeutic vaccine to restore the ability of a patient's immunological system to combat Alzheimer's disease. Alzamend Neuro, Inc. was incorporated in 2016 and is headquartered in Atlanta, Georgia.
Financial statements
Income Quarterly
| Metric | Q3 20262026-01-31 · USD | Q2 20262025-10-31 · USD | Q1 20262025-07-31 · USD | Q4 20252025-04-30 · USD | Q3 20252025-01-31 · USD | Q2 20252024-10-31 · USD | Q1 20252024-07-31 · USD | Q4 20242024-04-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | 0USD | 0USD | 0USD | 0USD | 0USD | 0USD | 0USD | 76,110USD |
| Cost Of Revenue | 27,685USD | 27,685USD | 27,685USD | 12,685USD | 12,685USD | 12,685USD | 12,685USD | 12,685USD |
| Gross Profit | -27,685USD | -27,685USD | -27,685USD | -12,685USD | -12,685USD | -12,685USD | -12,685USD | -12,685USD |
| Research Development | 1,278,629USD | 176,283USD | 1,740,867USD | 450,157USD | 447,111USD | 311,088USD | 206,571USD | 183,430USD |
| Selling General Administrative | 869,025USD | 821,826USD | 809,334USD | 685,484USD | 590,304USD | 742,980USD | 715,834USD | 666,635USD |
| Selling And Marketing Expenses | 50,000USD | — | 150,000USD | 3,295USD | — | 304,000USD | 40,000USD | 234,649USD |
| Total Operating Expenses | 2,197,654USD | 998,109USD | 2,700,201USD | 1,138,936USD | 1,037,415USD | 1,358,068USD | 962,405USD | 850,064USD |
| Operating Income | -2,197,654USD | -998,109USD | -2,700,201USD | -1,138,936USD | -1,037,415USD | -1,358,068USD | -962,405USD | -850,064USD |
| Interest Expense | 1,337USD | 2,649USD | 2,483USD | 509USD | 2,019USD | 3,495USD | 12,006USD | 1,465USD |
| Net Interest Income | -1,337USD | -2,649USD | -2,483USD | -509USD | -2,019USD | -3,495USD | -12,006USD | -1,465USD |
| Income Before Tax | -2,198,991USD | -1,000,758USD | -2,702,684USD | -1,139,445USD | -1,039,434USD | -1,361,563USD | -974,411USD | -851,530USD |
| Net Income | -2,198,991USD | -1,000,758USD | -2,702,684USD | -1,139,445USD | -1,039,434USD | -1,361,563USD | -974,411USD | -851,529USD |
| Net Income From Continuing Ops | -2,198,991USD | -1,000,758USD | -2,702,684USD | -1,139,445USD | -1,039,434USD | -1,361,563USD | -974,411USD | -851,530USD |
| Ebit | -2,197,654USD | -998,109USD | -2,700,201USD | -1,138,936USD | -1,037,415USD | -1,358,068USD | -962,405USD | -850,065USD |
| Ebitda | -2,169,969USD | -970,424USD | -2,672,516USD | -1,126,251USD | -1,024,730USD | -1,345,383USD | -949,720USD | -837,380USD |
| Depreciation And Amortization | 27,685USD | 27,685USD | 27,685USD | 12,685USD | 12,685USD | 12,685USD | 12,685USD | 12,685USD |
| Reconciled Depreciation | 27,685USD | 27,685USD | 27,685USD | 12,685USD | 12,685USD | 12,685USD | 12,685USD | 12,685USD |
| Total Other Income Expense Net | -1,337USD | -2,649USD | -2,483USD | -509USD | -2,019USD | -3,495USD | -12,006USD | -1,466USD |
| Other Operating Expenses | — | 998,109USD | — | — | — | — | 962,405USD | — |
| Income Tax Expense | — | — | — | — | — | — | — | -2USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Income Yearly
| Metric | FY 20252025-04-30 · USD | FY 20242024-04-30 · USD | FY 20232023-04-30 · USD | FY 20222022-04-30 · USD | FY 20212021-04-30 · USD | FY 20202020-04-30 · USD | FY 20192019-04-30 · USD | FY 20182018-04-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | 0USD | 0USD | 0USD | 0USD | 0USD | 0USD | 0USD | — |
| Cost Of Revenue | 50,740USD | 50,740USD | 23,066USD | — | — | — | — | — |
| Gross Profit | -50,740USD | -50,740USD | -23,066USD | — | — | — | — | — |
| Research Development | 1,414,928USD | 6,455,107USD | 7,445,857USD | 5,201,314USD | 1,310,716USD | 1,069,418USD | 3,700,083USD | 323,403USD |
| Selling General Administrative | 2,734,601USD | 3,235,204USD | 6,682,008USD | 7,100,567USD | 3,641,172USD | 3,354,743USD | 1,308,800USD | 545,118USD |
| Selling And Marketing Expenses | 347,295USD | 247,334USD | 742,601USD | 17,654USD | — | — | — | 29,909USD |
| Total Operating Expenses | 4,496,824USD | 9,937,645USD | 14,870,466USD | 12,319,535USD | 4,951,888USD | 4,424,161USD | 5,008,883USD | 898,430USD |
| Operating Income | -4,496,824USD | -9,937,645USD | -14,870,466USD | -12,319,535USD | -4,951,888USD | -4,424,161USD | -5,008,883USD | -898,000USD |
| Interest Expense | 18,029USD | 10,101USD | 7,701USD | 46,524USD | 158,803USD | 13,925USD | 0USD | 0USD |
| Net Interest Income | -18,029USD | -10,101USD | -7,701USD | -46,524USD | -157,097USD | 13,925USD | 146,387USD | — |
| Income Before Tax | -4,514,853USD | -9,947,746USD | -14,878,167USD | -12,362,059USD | -5,046,567USD | -4,410,236USD | -4,862,496USD | -932,000USD |
| Net Income | -4,514,853USD | -9,947,746USD | -14,878,167USD | -12,362,059USD | -5,046,567USD | -4,396,311USD | -4,862,496USD | -932,000USD |
| Net Income From Continuing Ops | -4,514,853USD | -9,947,747USD | -14,878,167USD | -12,362,059USD | -5,046,567USD | -4,410,236USD | -4,862,496USD | — |
| Ebit | -4,496,824USD | -9,937,645USD | -14,870,466USD | -12,315,535USD | -9,902,000USD | -4,424,161USD | -5,008,883USD | -891,089USD |
| Ebitda | -4,446,084USD | -9,886,905USD | -14,847,400USD | -12,311,986USD | -4,950,182USD | -4,424,161USD | -5,008,883USD | 7,341USD |
| Depreciation And Amortization | 50,740USD | 50,740USD | 23,066USD | 3,549USD | 4,952,000USD | 4,424USD | 5,009USD | 898,430USD |
| Reconciled Depreciation | 50,740USD | 50,740USD | 23,066USD | 3,549USD | 0USD | — | — | — |
| Total Other Income Expense Net | -18,029USD | -10,101USD | -7,701USD | -42,524USD | -94,679USD | 13,925USD | 146,387USD | -33,233USD |
| Income Tax Expense | — | — | -145,000USD | 42,524USD | 157,097USD | -13,925USD | -146,387USD | -898,000USD |
| Net Income Applicable To Common Shares | — | — | -14,878,167USD | -12,362,059USD | -5,046,567USD | -4,410,236USD | -4,862,496USD | -931,663USD |
| Interest Income | — | — | — | 0USD | 1,706USD | 13,925USD | 146,387USD | — |
| Non Operating Income Net Other | — | — | — | 4,000USD | 62,418USD | — | — | — |
| Other Operating Expenses | — | — | — | — | — | — | — | 898,430USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Balance sheet Quarterly
| Metric | Q1 20272026-07-31 · USD | Q4 20262026-04-30 · USD | Q3 20262026-01-31 · USD | Q2 20262025-10-31 · USD | Q1 20262025-07-31 · USD | Q4 20252025-04-30 · USD | Q3 20252025-01-31 · USD | Q2 20252024-10-31 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Assets | 8,542,061USD | 2,079,363USD | 4,041,833USD | 5,091,684USD | 6,326,751USD | 4,602,983USD | 4,175,634USD | 5,007,718USD |
| Cash And Equivalents | 7,591,444USD | 710,689USD | — | — | — | — | — | — |
| Total Current Assets | 8,254,880USD | 1,764,497USD | 3,699,282USD | 4,721,448USD | 5,928,830USD | 4,177,377USD | 3,947,343USD | 4,766,742USD |
| Other Current Assets | 663,436USD | 1,053,808USD | 986,143USD | 272,015USD | 307,958USD | 228,719USD | 589,208USD | 673,669USD |
| Total Liabilities | 2,739,381USD | 1,346,152USD | — | — | — | — | — | — |
| Total Stockholder Equity | 5,802,680USD | 733,211USD | 2,184,505USD | 4,374,196USD | 5,343,440USD | 3,968,222USD | 3,449,783USD | 3,752,968USD |
| Total Equity Including Noncontrolling Interest | 5,800,000USD | 733,211USD | — | — | — | — | — | — |
| Property Plant Equipment Net | 287,181USD | 314,866USD | 342,551USD | 370,236USD | 397,921USD | 425,606USD | 228,291USD | 240,976USD |
| Accounts Payable | 2,739,381USD | 1,346,152USD | 1,857,328USD | 717,488USD | 983,311USD | 634,761USD | 725,851USD | 1,254,750USD |
| Common Stock | 482USD | 425USD | 380USD | 380USD | 314USD | 78USD | 580USD | 523USD |
| Retained Earnings | -70,334,645USD | -67,307,643USD | -64,437,694USD | -62,238,703USD | -61,237,945USD | -58,535,261USD | -57,395,816USD | -56,410,033USD |
| Total Liab | — | — | 1,857,328USD | 717,488USD | 983,311USD | 634,761USD | 725,851USD | 1,254,750USD |
| Other Current Liab | — | — | 1,857,328USD | 717,488USD | 983,311USD | — | 725,851USD | 1,254,750USD |
| Capital Stock | — | — | 380USD | 380USD | 314USD | 78USD | 580USD | 523USD |
| Cash | — | — | 2,713,139USD | 4,449,433USD | 5,620,872USD | 3,948,658USD | 3,358,135USD | 4,093,073USD |
| Cash And Short Term Investments | — | — | 2,713,139USD | 4,449,433USD | 5,620,872USD | 3,948,658USD | 3,358,135USD | 4,093,073USD |
| Total Current Liabilities | — | — | 1,857,328USD | 717,488USD | 983,311USD | 634,761USD | 725,851USD | 1,254,750USD |
| Net Debt | — | — | -2,713,139USD | -4,449,433USD | -5,620,872USD | -3,948,658USD | -3,358,135USD | -4,093,073USD |
| Common Stock Shares Outstanding | — | — | 3,804,741shares | 3,380,968shares | 2,106,036shares | 711,271shares | 613,088shares | 392,411shares |
| Non Current Assets Total | — | — | 342,551USD | 370,236USD | 397,921USD | 425,606USD | 228,291USD | 240,976USD |
| Non Current Liabilities Total | — | — | 0USD | 0USD | 0USD | 0USD | 0USD | 0USD |
| Net Working Capital | — | — | 1,841,954USD | 4,003,960USD | 4,945,519USD | 3,542,616USD | 3,221,492USD | 3,511,992USD |
| Unclassified Current Liabilities | — | — | -1,857,328USD | — | — | — | — | -1,254,750USD |
| Unclassified Equity | — | — | 66,621,439USD | 66,612,139USD | 66,580,757USD | 62,503,327USD | 60,844,439USD | 60,161,955USD |
| Source | DisclosureDeterministicFinal | DisclosureDeterministicFinal | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Balance sheet Yearly
| Metric | FY 20262026-04-30 · USD | FY 20252025-04-30 · USD | FY 20242024-04-30 · USD | FY 20232023-04-30 · USD | FY 20222022-04-30 · USD | FY 20212021-04-30 · USD | FY 20202020-04-30 · USD | FY 20192019-04-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Assets | 2,079,363USD | 4,602,983USD | 631,588USD | 5,915,625USD | 14,516,443USD | 2,912,590USD | 1,814,015USD | 1,500,917USD |
| Cash And Equivalents | 710,689USD | — | — | — | — | — | — | — |
| Total Current Assets | 1,764,497USD | 4,177,377USD | 455,242USD | 5,835,782USD | 14,413,534USD | 2,912,590USD | 1,814,015USD | 1,500,917USD |
| Other Current Assets | 1,053,808USD | 228,719USD | 79,194USD | 694,923USD | 349,723USD | 614,608USD | 1,529,452USD | 1,172,957USD |
| Total Liabilities | 1,346,152USD | — | — | — | — | — | — | — |
| Total Stockholder Equity | 733,211USD | 3,968,222USD | -2,594,185USD | 3,045,503USD | 13,351,511USD | 2,012,947USD | 821,709USD | 316,915USD |
| Total Equity Including Noncontrolling Interest | 733,211USD | — | — | — | — | — | — | — |
| Property Plant Equipment Net | 314,866USD | 425,606USD | 176,346USD | 79,843USD | 102,909USD | 0USD | — | — |
| Accounts Payable | 1,346,152USD | 634,761USD | 2,925,059USD | 2,870,122USD | 1,162,850USD | 503,591USD | 929,639USD | 1,104,669USD |
| Common Stock | 425USD | 78USD | 69USD | 9,694USD | 9,548USD | 6,743USD | 6,476USD | 6,188USD |
| Retained Earnings | -67,307,643USD | -58,535,261USD | -54,020,408USD | -44,072,662USD | -29,194,495USD | -16,832,436USD | -11,785,869USD | -7,375,633USD |
| Total Liab | — | 634,761USD | 3,225,773USD | 2,870,122USD | 1,164,932USD | 899,643USD | 992,306USD | 1,184,002USD |
| Capital Stock | — | 78USD | 69USD | 9,694USD | 9,548USD | 6,818USD | 6,551USD | 6,263USD |
| Cash | — | 3,948,658USD | 376,048USD | 5,140,859USD | 14,063,811USD | 1,929,270USD | 90,285USD | 42,606USD |
| Cash And Short Term Investments | — | 3,948,658USD | 376,048USD | 5,140,859USD | 14,063,811USD | 1,929,270USD | 90,285USD | 42,606USD |
| Total Current Liabilities | — | 634,761USD | 3,225,773USD | 2,870,122USD | 1,164,932USD | 899,643USD | 992,306USD | 1,184,002USD |
| Net Debt | — | -3,948,658USD | -75,334USD | -5,140,859USD | -14,063,811USD | -1,593,967USD | -90,222USD | -42,527USD |
| Common Stock Shares Outstanding | — | 450,799shares | 75,174shares | 72,236shares | 65,997shares | 53,815shares | 52,780shares | 43,587shares |
| Non Current Assets Total | — | 425,606USD | 176,346USD | 79,843USD | 102,909USD | 352,501USD | 0USD | 0USD |
| Non Current Liabilities Total | — | 0USD | 0USD | 0USD | 1,162,850USD | 838,894USD | 929,639USD | 1,104,669USD |
| Net Working Capital | — | 3,542,616USD | -2,770,531USD | 2,965,660USD | 13,248,602USD | 2,012,947USD | 821,709USD | 316,915USD |
| Unclassified Equity | — | 62,503,327USD | 51,426,085USD | 61,982,072USD | 57,410,205USD | 33,715,117USD | 27,577,751USD | 22,680,097USD |
| Other Current Liab | — | — | 3,225,773USD | 2,870,122USD | 2,082USD | 60,749USD | 62,604USD | 79,254USD |
| Current Deferred Revenue | — | — | -3,225,773USD | — | — | — | -63USD | -79USD |
| Short Term Debt | — | — | 300,714USD | — | — | 335,303USD | 63USD | 79USD |
| Short Long Term Debt | — | — | 300,714USD | — | — | 335,303USD | — | — |
| Short Long Term Debt Total | — | — | 300,714USD | — | — | 335,303USD | 63USD | 79USD |
| Accumulated Other Comprehensive Income | — | — | 0USD | -14,883,295USD | -14,883,295USD | -14,883,295USD | -14,983,200USD | -15,000,000USD |
| Unclassified Current Liabilities | — | — | -3,526,487USD | -2,870,122USD | — | — | — | — |
| Other Assets | — | — | — | 0USD | 0USD | -352,501USD | — | — |
| Non Currrent Assets Other | — | — | — | 0USD | 0USD | 352,501USD | — | — |
| Net Tangible Assets | — | — | — | 3,045,503USD | 13,351,511USD | 2,012,872USD | 821,634USD | 316,840USD |
| Unclassified Non Current Liabilities | — | — | — | — | 1,162,850USD | — | — | 1,104,669USD |
| Net Receivables | — | — | — | — | — | 16,210USD | 194,278USD | 285,354USD |
| Inventory | — | — | — | — | — | -16,210USD | — | — |
| Source | DisclosureDeterministicFinal | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Cash flow Quarterly
| Metric | Q1 20272026-07-31 · USD | Q3 20262026-01-31 · USD | Q2 20262025-10-31 · USD | Q1 20262025-07-31 · USD | Q4 20252025-04-30 · USD | Q3 20252025-01-31 · USD | Q2 20252024-10-31 · USD | Q1 20252024-07-31 · USD |
|---|---|---|---|---|---|---|---|---|
| Depreciation | 27,685USD | 27,685USD | 27,685USD | 27,685USD | 12,685USD | 12,685USD | 12,685USD | 12,685USD |
| Stock Based Compensation | 77,199USD | 9,300USD | 31,514USD | 42,902USD | 81,277USD | 81,277USD | 81,277USD | 81,277USD |
| Change To Liabilities | 1,393,229USD | — | — | — | — | — | — | — |
| Change In Working Capital | 1,783,601USD | -714,128USD | -229,880USD | 269,311USD | 356,778USD | -531,817USD | 184,579USD | -184,579USD |
| Operating Cash Flow | -1,138,517USD | — | — | — | — | — | — | — |
| Financing Cash Flow | 8,019,272USD | — | — | — | — | — | — | — |
| Change In Cash | 6,880,755USD | -1,736,294USD | -1,171,439USD | 1,672,214USD | 590,523USD | -734,938USD | 2,899,123USD | 817,902USD |
| End Cash Flow | 7,591,444USD | — | — | — | — | — | — | — |
| Net Income | — | -2,198,991USD | -1,000,758USD | -2,702,684USD | -1,139,445USD | -985,783USD | -1,415,214USD | -974,411USD |
| Other Non Cash Items | — | 1,139,840USD | -229,880USD | 42,902USD | 81,277USD | 134,928USD | -2,263,428USD | 9,286USD |
| Total Cash From Operating Activities | — | -1,736,294USD | -1,171,439USD | -2,362,786USD | -688,705USD | -1,423,638USD | -3,400,101USD | -1,055,742USD |
| Capital Expenditures | — | 0USD | 0USD | 0USD | -210,000USD | 0USD | -90,000USD | -90,000USD |
| Free Cash Flow | — | -1,736,294USD | -1,171,439USD | -2,362,786USD | -898,705USD | -1,423,638USD | -3,310,101USD | -1,145,742USD |
| Total Cash From Financing Activities | — | 0USD | 0USD | 4,035,000USD | 1,489,228USD | 688,700USD | 6,299,224USD | 1,963,644USD |
| Issuance Of Capital Stock | — | 0USD | 0USD | 4,035,000USD | 1,488,628USD | 688,700USD | 6,299,224USD | 1,963,644USD |
| Begin Period Cash Flow | — | 4,449,433USD | 5,620,872USD | 3,948,658USD | 3,358,135USD | 4,093,073USD | 1,193,950USD | 376,048USD |
| End Period Cash Flow | — | 2,713,139USD | 4,449,433USD | 5,620,872USD | 3,948,658USD | 3,358,135USD | 4,093,073USD | 1,193,950USD |
| Investments | — | — | — | 0USD | -210,000USD | 0USD | 0USD | -90,000USD |
| Other Cashflows From Financing Activities | — | — | — | 4,035,000USD | 648,100USD | 87,379USD | 6,299,224USD | 1,963,644USD |
| Unclassified Financing Cash Flow | — | — | — | -4,035,000USD | — | — | -6,299,224USD | -1,963,644USD |
| Total Cashflows From Investing Activities | — | — | — | — | -210,000USD | — | — | -90,000USD |
| Dividends Paid | — | — | — | — | — | -87,379USD | — | — |
| Other Cashflows From Investing Activities | — | — | — | — | — | -90,000USD | -90,000USD | — |
| Source | DisclosureDeterministicFinal | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Cash flow Yearly
| Metric | FY 20262026-04-30 · USD | FY 20252025-04-30 · USD | FY 20242024-04-30 · USD | FY 20232023-04-30 · USD | FY 20222022-04-30 · USD | FY 20212021-04-30 · USD | FY 20202020-04-30 · USD | FY 20192019-04-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Net Income | -8,772,382USD | -4,514,853USD | -9,947,746USD | -14,878,167USD | -12,362,059USD | -5,046,567USD | -4,410,236USD | -4,862,496USD |
| Depreciation | 110,740USD | 50,740USD | 50,740USD | 23,066USD | 3,549USD | 124,046USD | 3,549USD | 3,549USD |
| Stock Based Compensation | 707,527USD | 325,108USD | 955,633USD | 3,582,625USD | 4,408,569USD | 2,032,359USD | 1,801,516USD | 396,170USD |
| Change To Liabilities | 711,391USD | — | — | 1,707,272USD | 693,584USD | -413,242USD | -175,030USD | 1,014,581USD |
| Change In Working Capital | -113,698USD | -2,438,467USD | 670,666USD | 2,349,324USD | 1,327,181USD | -152,451USD | -299,347USD | 1,229,870USD |
| Operating Cash Flow | -8,067,813USD | — | — | — | — | — | — | — |
| Financing Cash Flow | 4,829,844USD | — | — | — | — | — | — | — |
| Change In Cash | -3,237,969USD | 3,572,610USD | -4,764,811USD | -8,922,952USD | 12,134,541USD | 1,838,985USD | 47,679USD | -502,395USD |
| End Cash Flow | 710,689USD | — | — | — | — | — | — | — |
| Other Non Cash Items | — | 9,286USD | 714USD | 1,707,272USD | 8,770USD | 454,632USD | 562,277USD | 2,191,256USD |
| Total Cash From Operating Activities | — | -6,568,186USD | -8,269,993USD | -8,923,152USD | -6,613,990USD | -2,712,027USD | -2,345,790USD | -1,045,200USD |
| Capital Expenditures | — | -300,000USD | -147,243USD | 0USD | -106,458USD | -106,458USD | -106,458USD | -106,458USD |
| Free Cash Flow | — | -6,868,186USD | -8,417,236USD | -8,923,152USD | -6,720,448USD | -2,712,027USD | -2,345,790USD | -1,045,200USD |
| Investments | — | -300,000USD | -147,243USD | -147,243USD | -106,458USD | 100,915USD | 105,000USD | 234,085USD |
| Total Cashflows From Investing Activities | — | -300,000USD | -147,243USD | — | -106,458USD | 100,915USD | 105,000USD | 234,085USD |
| Net Borrowings | — | 0USD | 300,000USD | 0USD | -58,667USD | 2,250,192USD | -16,666USD | 72,697USD |
| Total Cash From Financing Activities | — | 10,440,796USD | 3,652,425USD | 200USD | 18,854,989USD | 4,450,097USD | 2,288,469USD | 308,720USD |
| Issuance Of Capital Stock | — | 10,440,196USD | 3,352,425USD | 4,000,000USD | 18,911,456USD | 2,100,000USD | 2,288,335USD | 236,023USD |
| Begin Period Cash Flow | — | 376,048USD | 5,140,859USD | 14,063,811USD | 1,929,270USD | 90,285USD | 42,606USD | 545,000USD |
| End Period Cash Flow | — | 3,948,658USD | 376,048USD | 5,140,859USD | 14,063,811USD | 1,929,270USD | 90,285USD | 42,606USD |
| Other Cashflows From Financing Activities | — | 7,736,744USD | 2,100,000USD | 200USD | 18,854,989USD | 4,049,905USD | 2,288,469USD | 72,697USD |
| Unclassified Financing Cash Flow | — | -7,736,144USD | -2,100,000USD | — | -5,943,533USD | -3,950,000USD | -2,271,669USD | — |
| Sale Purchase Of Stock | — | — | — | 200USD | 6,002,200USD | 2,100,000USD | — | — |
| Cash And Cash Equivalents Changes | — | — | — | -8,922,952USD | 12,134,541USD | 1,838,985USD | — | — |
| Unclassified Operating Cash Flow | — | — | — | -1,707,272USD | — | — | — | — |
| Other Cashflows From Investing Activities | — | — | — | — | -5,374,509USD | 100,915USD | 105,000USD | 234,085USD |
| Unclassified Investing Cash Flow | — | — | — | — | 5,480,967USD | — | — | — |
| Source | DisclosureDeterministicFinal | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Operating metrics
No operating metrics are currently published for this company.
Revenue breakdown
No revenue breakdown is currently published for this company.
Periods follow company fiscal calendars. Quarterly, annual and year-to-date amounts are shown separately. Missing values are not zero. Data may be delayed, incomplete or corrected; follow the disclosure links to verify figures.